These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35812817)

  • 21. Elobixibat, the first-in-class Ileal Bile Acid Transporter inhibitor, for the treatment of Chronic Idiopathic Constipation.
    Miner PB
    Expert Opin Pharmacother; 2018 Aug; 19(12):1381-1388. PubMed ID: 30129377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review article: Elobixibat: a novel treatment for chronic constipation.
    Khanna L; Camilleri M
    Aliment Pharmacol Ther; 2021 Jan; 53(2):234-242. PubMed ID: 33296518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stepped-wedge randomised trial of laparoscopic ventral mesh rectopexy in adults with chronic constipation: study protocol for a randomized controlled trial.
    Grossi U; Stevens N; McAlees E; Lacy-Colson J; Brown S; Dixon A; Di Tanna GL; Scott SM; Norton C; Marlin N; Mason J; Knowles CH;
    Trials; 2018 Feb; 19(1):90. PubMed ID: 29402303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-World Comparison of Elobixibat and Lubiprostone Treatment in Patients with Chronic Constipation: A Propensity Score-Matched Analysis.
    Eguchi T; Yoshizaki T; Ikeoka S; Takagi M; Fujinami M; Matsuda T; Yamaguchi T; Nonaka T; Amioka S; Katayama N; Inoue K; Matsumoto M; Momose K; Sako T; Noda M; Morisawa T; Okada A
    Dig Dis; 2021; 39(4):341-350. PubMed ID: 33142288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation.
    Mosińska P; Fichna J; Storr M
    World J Gastroenterol; 2015 Jun; 21(24):7436-42. PubMed ID: 26139989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and safety of acupuncture and moxibustion for defecation dysfunction after sphincter-preserving surgery for rectal cancer: protocol for systematic review and meta-analysis.
    Xu G; Xiao Q; Lei H; Fu Y; Kong J; Zheng Q; Zhao L; Liang F
    BMJ Open; 2020 May; 10(5):e034152. PubMed ID: 32381535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elobixibat for the treatment of constipation.
    Wong BS; Camilleri M
    Expert Opin Investig Drugs; 2013 Feb; 22(2):277-84. PubMed ID: 23215781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised clinical trial: The ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation--a double-blind study.
    Simrén M; Bajor A; Gillberg PG; Rudling M; Abrahamsson H
    Aliment Pharmacol Ther; 2011 Jul; 34(1):41-50. PubMed ID: 21545606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial.
    Hegade VS; Kendrick SF; Dobbins RL; Miller SR; Richards D; Storey J; Dukes G; Gilchrist K; Vallow S; Alexander GJ; Corrigan M; Hirschfield GM; Jones DE
    BMC Gastroenterol; 2016 Jul; 16(1):71. PubMed ID: 27431238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol.
    Faqihi F; Alharthy A; Alodat M; Asad D; Aletreby W; Kutsogiannis DJ; Brindley PG; Karakitsos D
    Trials; 2020 Jun; 21(1):506. PubMed ID: 32513290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the consumption of a fermented dairy product containing Bifidobacterium lactis DN-173 010 on constipation in childhood: a multicentre randomised controlled trial (NTRTC: 1571).
    Tabbers MM; Chmielewska A; Roseboom MG; Boudet C; Perrin C; Szajewska H; Benninga MA
    BMC Pediatr; 2009 Mar; 9():22. PubMed ID: 19296845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery: a protocol for a single-centre, randomised controlled trial.
    Miura M; Inomata T; Nojiri S; Sung J; Nagao M; Shimazaki J; Midorikawa-Inomata A; Okumura Y; Fujio K; Akasaki Y; Kuwahara M; Huang T; Nakamura M; Iwagami M; Hirosawa K; Fujimoto K; Murakami A
    BMJ Open; 2022 Jan; 12(1):e052488. PubMed ID: 35105626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice.
    Yamauchi R; Takedatsu H; Yokoyama K; Yamauchi E; Kawashima M; Nagata T; Uchida Y; Kitaguchi T; Higashi T; Fukuda H; Tsuchiya N; Takata K; Tanaka T; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
    Hepatol Int; 2021 Apr; 15(2):392-404. PubMed ID: 33398776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic testing for dyssynergic defecation in chronic constipation: meta-analysis.
    Videlock EJ; Lembo A; Cremonini F
    Neurogastroenterol Motil; 2013 Jun; 25(6):509-20. PubMed ID: 23421551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of anorectal manometry on the outcome of treatment in severe childhood constipation: a randomized, controlled trial.
    van Ginkel R; Büller HA; Boeckxstaens GE; van Der Plas RN; Taminiau JA; Benninga MA
    Pediatrics; 2001 Jul; 108(1):E9. PubMed ID: 11433088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study protocol: long-term effect of the New Nordic Renal Diet on phosphorus and lipid homeostasis in patients with chronic kidney disease, stages 3 and 4: a randomised controlled trial.
    Hansen NM; Rix M; Kamper AL; Feldt-Rasmussen B; Christoffersen C; Astrup A; Salomo L
    BMJ Open; 2021 Aug; 11(8):e045754. PubMed ID: 34462278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elobixibat and its potential role in chronic idiopathic constipation.
    Acosta A; Camilleri M
    Therap Adv Gastroenterol; 2014 Jul; 7(4):167-75. PubMed ID: 25057297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human umbilical cord mesenchymal stem cells to treat spinal cord injury in the early chronic phase: study protocol for a prospective, multicenter, randomized, placebo-controlled, single-blinded clinical trial.
    Yang Y; Pang M; Chen YY; Zhang LM; Liu H; Tan J; Liu B; Rong LM
    Neural Regen Res; 2020 Aug; 15(8):1532-1538. PubMed ID: 31997819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.